Which are the causes of Marfan Syndrome?

Marfan syndrome is caused by a mutation in the FBN1 gene, which provides the instructions for producing fibrillin-1, a protein essential for the formation of elastic fibers in connective tissue.

The Genetic Mechanism

In the vast majority of cases, Marfan syndrome is an autosomal dominant condition, meaning a person only needs to inherit one copy of the mutated gene from an affected parent to develop the disorder. The FBN1 gene, located on chromosome 15, is responsible for creating a protein that acts like the "scaffolding" or "glue" that holds various tissues in the body together. When this protein is defective, the connective tissue—which supports the heart, eyes, and skeleton—becomes weakened and prone to stretching.

Spontaneous Mutations

While many individuals inherit Marfan syndrome from a parent, approximately 25% of cases arise from a de novo (spontaneous) mutation. This means the mutation occurs for the first time in the egg or sperm cell, or during early embryonic development, without a family history. In these instances, there are no known environmental triggers or lifestyle factors that cause the mutation; it is essentially a random biological "typo" in the genetic code.

Distinguishing Causes from Risk Factors

It is vital to distinguish between the cause of the disease and potential risk factors for health complications. The cause is strictly genetic. However, environmental factors—such as intense physical exertion or high blood pressure—can act as risk factors that exacerbate the severity of symptoms, particularly by putting extra strain on the weakened aorta. Marfan syndrome is not caused by autoimmune, infectious, or metabolic processes, nor can it be prevented by lifestyle changes.

Ongoing Research

Current research into Marfan syndrome is heavily focused on the TGF-beta signaling pathway. We now understand that the defective fibrillin-1 protein not only weakens tissue structure but also fails to regulate a growth factor called TGF-beta, leading to excessive inflammation and tissue remodeling. Clinical researchers are investigating how to better modulate this pathway to protect the cardiovascular system. While the primary genetic cause is well-understood, scientists continue to study why the severity of Marfan syndrome varies so greatly even among family members with the same genetic mutation.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• The Marfan Foundation


• Online Mendelian Inheritance in Man (OMIM)